These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6448739)

  • 1. Effect of insulin and nutrition on serum levels of somatomedin A in the rat.
    Takano K; Hizuka N; Shizume K; Hasumi Y; Kogawa M; Tsushima T
    Endocrinology; 1980 Nov; 107(5):1614-9. PubMed ID: 6448739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decrease in serum receptor-reactive somatomedin in diabetes.
    Baxter RC; Brown AS; Turtle JR
    Horm Metab Res; 1979 Mar; 11(3):216-20. PubMed ID: 221310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nutrition and somatomedin. XIV. Altered levels of somatomedins and somatomedin inhibitors in rats with streptozotocin-induced diabetes.
    Phillips LS; Fusco AC; Unterman TG
    Metabolism; 1985 Aug; 34(8):765-70. PubMed ID: 3160912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoid effects on IGF-1/somatomedin-C and somatomedin inhibitor in streptozotocin-diabetic rats.
    Hofert JF; Goldstein S; Phillips LS
    Metabolism; 1989 Jun; 38(6):594-600. PubMed ID: 2725299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatomedin inhibitor in uremia.
    Phillips LS; Fusco AC; Unterman TG; del Greco F
    J Clin Endocrinol Metab; 1984 Oct; 59(4):764-72. PubMed ID: 6384255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of somatomedin-like activity by serum from streptozotocin-diabetic rats: prevention by insulin treatment and correlation with skeletal growth.
    Taylor AM; Sharma AK; Avasthy N; Duguid IG; Blanchard DS; Thomas PK; Dandona P
    Endocrinology; 1987 Oct; 121(4):1360-5. PubMed ID: 2958269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nutrition and somatomedin. V. Action and measurement of somatomedin inhibitor(s) in serum from diabetic rats.
    Phillips LS; Belosky DC; Reichard LA
    Endocrinology; 1979 May; 104(5):1513-8. PubMed ID: 35341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutrition and somatomedin. XI. Studies of somatomedin inhibitors in rats with streptozotocin-induced diabetes.
    Phillips LS; Bajaj VR; Fusco AC; Matheson CK
    Diabetes; 1983 Dec; 32(12):1117-25. PubMed ID: 6653901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of nutrition on growth and somatomedin A levels in the rat.
    Takano K; Hizuka N; Shizume K; Hasumi Y; Tsushima T
    Acta Endocrinol (Copenh); 1980 Jul; 94(3):321-6. PubMed ID: 7424474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of glucocorticoid on body growth and serum levels of somatomedin A in the rat.
    Asakawa K; Takano K; Kogawa M; Hasumi Y; Shizume K
    Acta Endocrinol (Copenh); 1982 Jun; 100(2):206-10. PubMed ID: 7113591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nutrition and somatomedin. IX. Blunting of insulin-like activity by inhibitor in diabetic rat serum.
    Phillips LS; Scholz TD
    Diabetes; 1982 Feb; 31(2):97-104. PubMed ID: 6759235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nutrition and somatomedin. XXI. Insulin-like growth factor-I and somatomedin inhibitor in streptozotocin-diabetic rats: relation to ketogenesis and gluconeogenesis.
    Gagliardi AR; Goldstein S; Phillips LS
    Metabolism; 1990 Jan; 39(1):75-80. PubMed ID: 2403622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nutrition and somatomedin. XIX. Molecular regulation of insulin-like growth factor-1 in streptozotocin-diabetic rats.
    Goldstein S; Sertich GJ; Levan KR; Phillips LS
    Mol Endocrinol; 1988 Nov; 2(11):1093-100. PubMed ID: 2975756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutrition and somatomedin. II. Serum somatomedin activity and cartilage growth activity in streptozotocin-diabetic rats.
    Phillips LS; Young HS
    Diabetes; 1976 Jun; 25(6):516-27. PubMed ID: 132381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between serum insulin, serum somatomedin and liver receptors for human growth hormone in streptozotocin diabetes.
    Baxter RC; Brown AS; Turtle JR
    Horm Metab Res; 1980 Aug; 12(8):377-81. PubMed ID: 6250964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary protein restriction decreases insulin-like growth factor I independent of insulin and liver growth hormone binding.
    Maiter D; Fliesen T; Underwood LE; Maes M; Gerard G; Davenport ML; Ketelslegers JM
    Endocrinology; 1989 May; 124(5):2604-11. PubMed ID: 2523305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on somatomedin C in diabetic pregnancies].
    Murata K; Fujimoto K; Toyoda N; Kozuka Y; Maegawa T; Yoshimura K; Tanaka Y; Asakura T; Ichio T; Nomura H
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Feb; 38(2):223-8. PubMed ID: 3958519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nutrition and somatomedin. VI. Somatomedin activity and somatomedin inhibitory activity in sera from normal and diabetic rats.
    Phillips LS; Belosky DC; Young HS; Reichard LA
    Endocrinology; 1979 May; 104(5):1519-24. PubMed ID: 35342
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of thyroid hormone on the serum level of somatomedin A.
    Takano K; Hasumi Y; Hizuka N; Kogawa M; Tsushima T; Shizume K
    Endocrinol Jpn; 1980 Oct; 27(5):643-52. PubMed ID: 7238422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of cerebrocrast, a new long-acting compound on blood glucose and insulin levels in rats when administered before and after STZ-induced diabetes mellitus.
    Briede J; Stivrina M; Stoldere Dz; Vigante B; Duburs G
    Cell Biochem Funct; 2007; 25(6):673-80. PubMed ID: 16986170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.